Differential production of superoxide by neuronal mitochondria

<p>Abstract</p> <p>Background</p> <p>Mitochondrial DNA (mtDNA) mutations, which are present in all mitochondria-containing cells, paradoxically cause tissue-specific disease. For example, Leber's hereditary optic neuropathy (LHON) results from one of three point mu...

Full description

Bibliographic Details
Main Authors: Levin Leonard A, Lieven Christopher J, Hoegger Mark J
Format: Article
Language:English
Published: BMC 2008-01-01
Series:BMC Neuroscience
Online Access:http://www.biomedcentral.com/1471-2202/9/4
_version_ 1818389686855401472
author Levin Leonard A
Lieven Christopher J
Hoegger Mark J
author_facet Levin Leonard A
Lieven Christopher J
Hoegger Mark J
author_sort Levin Leonard A
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Mitochondrial DNA (mtDNA) mutations, which are present in all mitochondria-containing cells, paradoxically cause tissue-specific disease. For example, Leber's hereditary optic neuropathy (LHON) results from one of three point mutations mtDNA coding for complex I components, but is only manifested in retinal ganglion cells (RGCs), a central neuron contained within the retina. Given that RGCs use superoxide for intracellular signaling after axotomy, and that LHON mutations increase superoxide levels in non-RGC transmitochondrial cybrids, we hypothesized that RGCs regulate superoxide levels differently than other neuronal cells. To study this, we compared superoxide production and mitochondrial electron transport chain (METC) components in isolated RGC mitochondria to mitochondria isolated from cerebral cortex and neuroblastoma SK-N-AS cells.</p> <p>Results</p> <p>In the presence of the complex I substrate glutamate/malate or the complex II substrate succinate, the rate of superoxide production in RGC-5 cells was significantly lower than cerebral or neuroblastoma cells. Cerebral but not RGC-5 or neuroblastoma cells increased superoxide production in response to the complex I inhibitor rotenone, while neuroblastoma but not cerebral or RGC-5 cells dramatically decreased superoxide production in response to the complex III inhibitor antimycin A. Immunoblotting and real-time quantitative PCR of METC components demonstrated different patterns of expression among the three different sources of neuronal mitochondria.</p> <p>Conclusion</p> <p>RGC-5 mitochondria produce superoxide at significantly lower rates than cerebral and neuroblastoma mitochondria, most likely as a result of differential expression of complex I components. Diversity in METC component expression and function could explain tissue specificity in diseases associated with inherited mtDNA abnormalities.</p>
first_indexed 2024-12-14T04:45:41Z
format Article
id doaj.art-eaf49276a3a54d44995ee7ed93a6ee02
institution Directory Open Access Journal
issn 1471-2202
language English
last_indexed 2024-12-14T04:45:41Z
publishDate 2008-01-01
publisher BMC
record_format Article
series BMC Neuroscience
spelling doaj.art-eaf49276a3a54d44995ee7ed93a6ee022022-12-21T23:16:41ZengBMCBMC Neuroscience1471-22022008-01-0191410.1186/1471-2202-9-4Differential production of superoxide by neuronal mitochondriaLevin Leonard ALieven Christopher JHoegger Mark J<p>Abstract</p> <p>Background</p> <p>Mitochondrial DNA (mtDNA) mutations, which are present in all mitochondria-containing cells, paradoxically cause tissue-specific disease. For example, Leber's hereditary optic neuropathy (LHON) results from one of three point mutations mtDNA coding for complex I components, but is only manifested in retinal ganglion cells (RGCs), a central neuron contained within the retina. Given that RGCs use superoxide for intracellular signaling after axotomy, and that LHON mutations increase superoxide levels in non-RGC transmitochondrial cybrids, we hypothesized that RGCs regulate superoxide levels differently than other neuronal cells. To study this, we compared superoxide production and mitochondrial electron transport chain (METC) components in isolated RGC mitochondria to mitochondria isolated from cerebral cortex and neuroblastoma SK-N-AS cells.</p> <p>Results</p> <p>In the presence of the complex I substrate glutamate/malate or the complex II substrate succinate, the rate of superoxide production in RGC-5 cells was significantly lower than cerebral or neuroblastoma cells. Cerebral but not RGC-5 or neuroblastoma cells increased superoxide production in response to the complex I inhibitor rotenone, while neuroblastoma but not cerebral or RGC-5 cells dramatically decreased superoxide production in response to the complex III inhibitor antimycin A. Immunoblotting and real-time quantitative PCR of METC components demonstrated different patterns of expression among the three different sources of neuronal mitochondria.</p> <p>Conclusion</p> <p>RGC-5 mitochondria produce superoxide at significantly lower rates than cerebral and neuroblastoma mitochondria, most likely as a result of differential expression of complex I components. Diversity in METC component expression and function could explain tissue specificity in diseases associated with inherited mtDNA abnormalities.</p>http://www.biomedcentral.com/1471-2202/9/4
spellingShingle Levin Leonard A
Lieven Christopher J
Hoegger Mark J
Differential production of superoxide by neuronal mitochondria
BMC Neuroscience
title Differential production of superoxide by neuronal mitochondria
title_full Differential production of superoxide by neuronal mitochondria
title_fullStr Differential production of superoxide by neuronal mitochondria
title_full_unstemmed Differential production of superoxide by neuronal mitochondria
title_short Differential production of superoxide by neuronal mitochondria
title_sort differential production of superoxide by neuronal mitochondria
url http://www.biomedcentral.com/1471-2202/9/4
work_keys_str_mv AT levinleonarda differentialproductionofsuperoxidebyneuronalmitochondria
AT lievenchristopherj differentialproductionofsuperoxidebyneuronalmitochondria
AT hoeggermarkj differentialproductionofsuperoxidebyneuronalmitochondria